Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESOC 2025 | Simplification of imaging for acute stroke triage with artificial intelligence software

Santiago Ortega-Gutierrez, MD, MSc, FAHA, FSVIN, The University of Iowa, Iowa City, IA, comments on the simplification of imaging in acute stroke triage, highlighting the development of artificial intelligence software that simplifies the triage process. This could enable the identification of large vessel occlusions with similar accuracy to CT perfusion, and Dr Ortega-Gutierrez highlights plans to evaluate the efficacy of this method in the DAWN-SIMPLE trial. This interview took place at the 11th European Stroke Organisation Conference (ESOC) in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Simplification of imaging for acute stroke triage has been also part of our journey for a few years. Over the last two years we have developed, we have helped to develop, working with some companies, artificial intelligence software that really simplifies the triage process. With a plain CT, now we are able to identify large vessel occlusions as well as estimate the volume with a similar accuracy to a CT perfusion...

Simplification of imaging for acute stroke triage has been also part of our journey for a few years. Over the last two years we have developed, we have helped to develop, working with some companies, artificial intelligence software that really simplifies the triage process. With a plain CT, now we are able to identify large vessel occlusions as well as estimate the volume with a similar accuracy to a CT perfusion. Then basically the next step, and we have already initiated the trial called the DAWN-SIMPLE trial, is we are trying to evaluate if selecting patients with simple imaging and enhanced by AI capabilities, we could actually have the similar efficacy results to just advanced imaging when there is a high suspicion for large vessel occlusion. This study is going to be also selecting patients, randomizing patients in the ultra-late window, 24 to 72 hours, and the hope is that if this is a positive trial, imaging simplification will be much more generalizable in low and middle income countries, and everybody will have the capabilities of screening these patients without the need of high sophisticated software.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Disclosures

Grants: MeThinks.